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Abstract
Background: There are several studies with varied and mixed results about the possible relationship between H.
pylori and diabetes. Therefore, this current meta-analysis performed to determine the association between H. pylori
infection and the risk of diabetes mellitus.
Methods: A systematic literature searches of international databases, including Medline (PubMed), Web of Sciences,
Scopus, EMBASE, and CINHAL (January 1990–March 2019) was conducted to identify studies investigating the
relationship between H. pylori infection and diabetes mellitus. Only case–control studies were analyzed using odds
ratio (OR) with 95% confidence intervals (CIs). Stratified and subgroup analyses were performed to explore
heterogeneity between studies and assess effects of study quality. Logarithm and standard error logarithm odds
ratio (OR) were also used for meta-analysis.
Results: A total of 41 studies involving 9559 individuals (case; 4327 and control; 5232) were analyzed. The pooled
estimate of the association between H. pylori infection with diabetes was OR = 1.27 (95% CI 1.11 to 1.45, P = 0.0001,
I2 = 86.6%). The effect of H. pylori infection on diabetes mellitus (both types), type 1 and type 2 diabetes was 1.17
(95% CI 0.94 to 1.45), 1.19 (95% CI 0.98 to 1.45), and 1.43 (95% CI 1.11 to 1.85) respectively. Subgroup analysis by the
geographical regions showed in Asian population risk of the effect of H. pylori infection on diabetes was slightly
higher than other population,
Conclusion: In overall a positive association between H. pylori infection and diabetes mellitus was found.
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Background
Helicobacter pylori (H. pylori) is a gram-negative spiral
bacterium which is found abundantly in the stomach.
The H. pylori infection is one of the most common
chronic infections in the world, so that more than 50%
of the world’s population are infected with this infection
[1, 2]. It is now known that H. pylori is responsible for
most cases of peptic ulcer disease. Also, the different
studies highlighted that it is associated with other im-
portant gastrointestinal diseases such as chronic gastritis,
gastric adenocarcinoma, and MALT lymphoma which
are recognized as a major public health concern in the
world [3, 4]. In addition to the role of H. pylori in
gastrointestinal disorders, some researches have sug-
gested the potential role of this bacterium in the devel-
opment of non-gastrointestinal disorders such as
cardiovascular diseases and metabolic syndrome espe-
cially diabetes [5–7]. Diabetes is the most common
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metabolic disease in the world and responsible for about 4
million deaths per year. The global prevalence of diabetes
was 4.6% equivalent to 285 million in adults for 2010,
which this number has reached 371 million in 2012, and is
expected to reach 552 million by 2030 [8–10].
As mentioned above, one of the factors that may affect
incidence of diabetes is H. pylori. The relationship be-
tween H. pylori infection and diabetes was introduced in
1989 [11]. It has been suggested that the H. pylori may
be contributed to the incidence of cardiovascular disease
and diabetes through elevations in inflammatory cyto-
kines levels such as C-reactive protein (CRP) and
interleukin-6 [11–13]. In general, various studies have
investigated the role of H. pylori in the pathogenesis of
diabetes and its complications, but the results are incon-
sistent with each other. For example, some case-control
studies have reported higher prevalence of H. pylori in
patients with diabetes [14, 15]. Also, several cross-
sectional studies have shown a significant statistical asso-
ciation between H. pylori and diabetes [3, 15]. However,
some studies in this regard have shown that there is no
significant association between diabetes and prevalence
H. pylori infection [2, 16, 17].
Therefore, the association between H. pylori infection
and the risk of diabetes is still controversies. Hence, this
systematic review and meta-analysis study was designed
to identify the possible association between H. pylori in-
fection and the risk of diabetes.
Methods
This systematic review and Meta-analysis was performed
according to the Preferred Reporting Items for System-
atic Reviews and Meta-analyses (PRISMA) and Strength-
ening the Reporting of Observationally Studies in
Epidemiology (STROBE) guidelines for reviews of ana-
lytical observational studies (case-control) [18–20].
Search terms and complex search syntax
All original published articles were searched from Janu-
ary 1990 to March 2019 without language limitations in
international databases, including Medline (PubMed),
Web of Sciences, Scopus, EMBASE, Cochrane, Ovid and
CINHAL. The keywords were Diabetes, Diabetes Melli-
tus (type 1 and 2), Insulin Dependent, IDDM, NIDDM,
Noninsulin Dependent, Insulin Sensitivity, Helicobacter
pylori, Campylobacter pylori, and H Pylori. Two re-
viewers (YM and RR) abstracted data independently and
reached consensus on all items. Inclusion and exclusion
criteria were set by two researchers separately (YM and
RR) (Fig. 1).
Eligibility criteria
A published study had to meet the following inclusion
criteria:
(1) case-control, nested case control studies, (2) hu-
man population, and (3) Helicobacter pylori infection
was exposure variable. Case reports, reviews, animal
studies, and cohort studies were removed from the tabu-
lation. The authors resolved all disputes during the col-
lection, compilation, and analysis of data.
Data extraction
Two reviewers (YM and RR) independently extracted
the data. A structured checklist was used for the extrac-
tion of information including; 1) name of first author, 2)
date of publication, 3) country, 4) study subjects, 5) age
of patients, 6) sample size, 7) type of diabetes, 8) mean
of HbA1C, 9) duration of diabetes, 10) measurement of
association, 11) controlled variables, 12) and method of
bacteria detection. In addition, type of instruments (de-
tection of H. pylori) was extracted from each study in
case of reporting. A data extraction form was created
based on our group discussion and piloted according to
10 different types of studies. Then, it was modified and
used by the data extractor. All process from systematic
search to final data extraction were followed independ-
ently by two research experts (Kappa statistic for agree-
ment for quality assessment; 0.75). Any disagreement
was assessed by both and if a consensus was not
reached, a third author (LS) evaluate the study. The
qualities of all studies were assessed by Modified
Newcastle-Ottawa Scale for Case Control studies [21].
Statistical analysis
Logarithm and standard error logarithm odds ratio (OR)
were used for the meta-analysis. DerSimonian and Laird
method was used to compute the pooled estimate of
odds ratio (OR) with confidence interval (CI 95%) using
random models [22]. Because the test for heterogeneity
was statistically significant in some analyses, the random
effects models were used to estimate OR. In this study, w
Cochran’s Q test and I2 statistic were used to evaluate
statistical heterogeneity between studies [23]. In addition,
a meta-regression and subgroup analysis were performed
to assess the source of heterogeneity between studies.
Moreover, publication bias was assessed by funnel plot
and Egger test [24, 25]. Statistical analysis was performed
using STATA 14.0 (Stata Corp, College Station, TX,
USA), and statistical significance was set at p < 0.05.
Results
Study characteristics
The first step of search in electronic databases yielded 2027
publications and 200 studies identified through other
sources. In the final step, after removing the duplicates,
reviewing by title, abstract and full text and considering the
inclusion and exclusion criteria, 41 studies were selected
for the meta-analysis of pooled association between H.
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pylori infection and the risk of diabetes (Fig. 1). Characteris-
tics of included studies in this meta-analysis are reported in
Table 1. The total sample size in the 41 studies that re-
ported the association between H. pylori infection and the
risk of diabetes in case and control was 4327 and 5232, re-
spectively. Also, 11 studies reported association between H.
pylori infection with DM. Other primary studies reported
association between H. pylori infection with type 1 and 2
diabetes. A total of 41 studies were included in this meta-
analysis, of which 20 were conduct in European, 12 were in
Asian, 7 studies done in African and 2 in American
(Table 2). Of the 41 studies, 18 showed statistically signifi-
cant between H. pylori infection and the risk of diabetes.
The pooled estimate of the association between H. pyl-
ori infection with diabetes mellitus was 1.27 (95% CI
1.11 to 1.45, P = 0.0001, I2 = 86.6%) (Fig. 2), but since the
CI of test (Egger’s test) included zero, no significant bias
occurred in the publication of the results (Egger’s test =
1.579, P = 0.073, 95% CI − 0.154 to 3.312) (Fig. 3).
Subgroup analysis
Based on the random effect model, the effect of H. pylori
infection on diabetes mellitus, type 1 and type 2 diabetes
was 1.17 (95% CI 0.94 to 1.45), 1.19 (95% CI 0.98 to
1.45), and 1.43 (95% CI 1.11 to 1.85) respectively. Effect
size of H. pylori infection on type 2 diabetes was higher
than type 1 and diabetes mellitus (Table 2). Some of the
primary studies did not mention that the study popula-
tion was type 1 or type 2, therefore we decided to in-
clude these types of studies as diabetes mellitus group in
subgroup analysis.
Subgroup analysis by the geographical regions showed
in Asian population risk of the effect of H. pylori infec-
tion on diabetes was higher than other population. In
Fig. 1 Flow Diagram of the Literature Search and Study Selection
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Fig. 2 Association between Helicobacter pylori and Risk of diabetes (DM, T2DM and T1DM)
Fig. 3 Funnel plot of association between Helicobacter pylori and Risk of diabetes
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addition, the relationship between H. pylori and the risk
of diabetes according to age showed that risk in individ-
ual with 30 to 60 years was 1.34 (95% CI 1.09, 1.65), in
10 to 30 years, and upper 60 years was 1.34 (95% CI
1.05, 1.62) and 1.03 (95% CI 0.93, 3.23), respectively
(Table 2).
The effect of H. pylori infection on diabetes mellitus
by non- invasive testes detected was higher than invasive
tests methods, (Table 2).
Discussion
Our systematic review and meta-analysis suggest that
there is a positive association between H. pylori infection
and diabetes. The results showed a significant statistical
association between H. pylori infection and the risk of
diabetes (overall OR: 1.27; 95% CI: 1.11–1.45). The re-
sults of subgroup analysis by type of diabetes revealed a
significant association between H. pylori infection and
the risk of type 2 diabetes (OR: 1.43; 95% CI: 1.11–1.85).
However, this meta-analysis showed a positive relation-
ship between H. pylori and the risk of type 1 diabetes
(OR: 1.19; 95% CI: 0.98–1.45) and diabetes mellitus (OR:
1.17; 95% CI: 0.94–1.45) but statistically were not signifi-
cant. Subgroup analysis by the geographical regions
showed a significant direct relationship between H. pyl-
ori and the risk of diabetes in Asian, Europe and Africa
but in the American population this association was
negative. In addition, in subgroup analysis, the relation-
ship between H. pylori and the risk of diabetes was dif-
ferent based to age, level of HbA1C, duration of diabetes
and methods for H. pylori detection. This suggests that
these factors could be an important source of heterogen-
eity in the studies included in the meta-analysis.
Our meta-analysis suggests that H. pylori infection
may increase the risk of diabetes by up to 27%. These
findings are consistent with the results of several meta-
analysis studies that have been done in this field. Ac-
cording to our knowledge, three other meta-analysis
studies have been conducted regarding the association
between H. pylori and diabetes. The first study which
has been conducted by Jun-Zhen Li on 79 studies with
57,397 individuals from January 1996 to January 2016,
showed that the prevalence of H. pylori infection in dia-
betes mellitus patients was significantly higher than non-
diabetic (OR: 1.69; 95% CI: 1.47–1.95), however, this dif-
ference was only significant for type 2 diabetes (OR:
2.05; 95% CI: 1.67–2.52) [2]. The second study that was
carried out by FENG WANG on 39 eligible studies for
meta-analysis form 1997 and 2012, revealed that the H.
pylori infection also associated with increased risks of
type 1 (OR: 1.99, 95% CI 1.52–2.60) and type 2 diabetes
(OR: 2.15, 95% CI 1.81–2.55) [63]. In the third meta-
analysis study by Zhou et al. on 41 articles and 14,080
participants, the results reveled a significant association
between H. pylori infection and increased risks of dia-
betes (OR: 1.33; 95% CI: 1.08–1.64) [64]. However, some
studies did support significant association between H.
pylori infection and the risk of diabetes [16, 65].
Several mechanisms have been proposed for the rela-
tionship between H. pylori infection and risk of diabetes.
Inflammatory cytokine may lead to induce phosphoryl-
ation of serine residues on the insulin receptor substrate
and subsequently this phenomenon may impair the
interaction between the substrate and the insulin recep-
tors due to impaired insulin function [7, 66]. Also, Lipo-
polysaccharides from gram-negative bacteria such as H.
pylori may activate Toll-like receptors and subsequently
insulin resistance occurs [67]. All of these events can
lead to reduced blood sugar control and consequently
diabetes mellitus. In addition, the presence of bacterial
infections can lead to microvascular failure and eventu-
ally incidence of atherosclerosis [68].
In subgroup analysis of geographical regions by the
type of continent, we explored a significant direct rela-
tionship between H. pylori and the risk of diabetes in
Asian, Europe and Africa but not in the American, how-
ever there was still high heterogeneity within these sub-
groups, therefore the interpretation of this negative
result would be difficult. This was consistent with study
of Jun-Zhen Li et al. that have shown H. pylori infection
is significantly higher in patients with diabetes residing
in Asia and Europe than in Africa and the American
[69]. Also, Wang F et al. reported H. pylori can increase
the risk of diabetes in European, Middle East and South
Asia [63]. But, study carried out by Zhou et al. found H.
pylori infection is significantly higher in patients with
diabetes residing in only Asia [64]. This difference in
various continents may be due to differences in sample
size, different diagnostic methods and different medical
care conditions. However, to determine the precise effect
of geographical location on the association between H.
pylori and diabetes risk, it is suggested to carry out fur-
ther studies to look at the role of genetic and environ-
mental factors particularly in migrant populations.
Also, in subgroup analysis, we found a significant dir-
ect relationship between H. pylori and the risk of dia-
betes in mean of HbA1C > 8. This result was in line
with the results of other studies in this field. For ex-
ample, the study by Ming-Chia Hsieh et al. revealed that
there is a significant and direct statistical relationship
between prevalence of H. pylori and serum HbA1c levels
but not fasting glucose levels after adjusting for sex, age,
BMI and family history of diabetes mellitus, so that the
positive H. pylori group had significantly higher serum
HbA1c levels compared to the negative H. pylori group
(5.78% vs. 5.69%, p = 0.007) [70]. Another study in China
revealed individuals with H. pylori infection had a higher
level HbA1C than those who did not [71]. Considering
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the HbA1c is a valid and reliable indicator for estimating
average blood sugar in long-term, it seems to be more
valid to evaluate the effect of chronic H. pylori infection
on blood glucose regulation, because fasting glucose
levels are subject to daily changes such as diet and phys-
ical activity which these fluctuations may impair any as-
sociation between H. pylori infection and glucose
regulation [72–74]. In addition, in subgroup analysis re-
lationship between H. pylori and the risk of diabetes was
different by age. This finding was consistent with results
of other reports, because the different studies have
shown that the prevalence of H. pylori infection varies
with age [75].
Finally, association between H. pylori and the risk of dia-
betes was different by methods for H. pylori detection in
subgroup analysis. This suggests that this factor could be
an important source of heterogeneity in the studies in-
cluded in the meta-analysis, because different methods of
detection for H. pylori had different accuracy and preci-
sion in such cases the serological tests of anti- H. pylori
IgG or/and IgA antibody in serum may be reported with
different degree of false positives [76, 77]. As a result, as-
sociation H. pylori and the risk of diabetes may be differ-
ent according to the method of diagnosis of infection.
Strengths and limitations
This study similar to other studies has some limitations
and strengths.
One of the issue which make distinguish this meta-
analysis with the previous ones is dealing with heterogen-
eity through a subgroups analysis based on type of diabetes,
geographical regions, age, and level of HbA1c, duration of
diabetes and detection methods of H. pylori. Another
strength point of our meta-analysis is considering as much
as reported and published studies in comparison with other
systematic reviews (41 studies) that we were unable to in-
vestigate the exact effect of the publication bias.
Also, this study has some limitations. Firstly, missing
potential studies e.g. limiting full- text review to English
language articles may be lead to some degree of selection
bias. Secondly, all studies included in meta-analysis were
case-control, hence, the design and implementation of
cohort studies are essential for detailed assessment of
the association between H. pylori infection and diabetes.
Thirdly, personal judgments may be effect on search of
articles, data extraction and assessment of included arti-
cles in meta-analysis.
Conclusion
According to this systematic review & meta-analysis, it
can be concluded that H. pylori infection could be a po-
tential risk factor for diabetes particularly type 2 dia-
betes, however further prospective studies are necessary
to show the direction of this association.
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